$ATRA Atara Biotherapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Atara Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Atara Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atara Biotherapeutics, Inc. for free.
CIK Number: 0001604464
IRS Number: 460920988
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ATRA
Company Address: 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO 94080
Market Capitalization: $434.34M
Prev close: $15.05
Average Daily Volume: 231,402
Days Low: $14.70
Year Low: $12.45
Year High: $25.73
Atara Biotherapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | ATRA | Atara Biotherapeut ... | Yarema Kristin | Chief Commercial Of ... | Buy | P | 14.58 | 28,833 | 420,385 | 125,882 | 97 K to 125.9 K (+29.71 %) |
Jun 15 2021 | ATRA | Atara Biotherapeut ... | Yarema Kristin | Chief Commercial Of ... | Buy | P | 14.48 | 3,500 | 50,680 | 97,049 | 93.5 K to 97 K (+3.74 %) |
Jun 15 2021 | ATRA | Atara Biotherapeut ... | Yarema Kristin | Chief Commercial Of ... | Buy | P | 14.50 | 2,021 | 29,305 | 93,549 | 91.5 K to 93.5 K (+2.21 %) |
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Grant | A | 0.00 | 11,000 | 0 | 23,000 | 12 K to 23 K (+91.67 %) | |
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Baynes Roy D. | Grant | A | 0.00 | 11,000 | 0 | 23,000 | 12 K to 23 K (+91.67 %) | |
Jun 09 2021 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
Jun 09 2021 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Grant | A | 0.00 | 11,000 | 0 | 38,189 | 27.2 K to 38.2 K (+40.46 %) | |
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Renaud Ronald C JR | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
Jun 09 2021 | ATRA | Atara Biotherapeut ... | Renaud Ronald C JR | Grant | A | 0.00 | 11,000 | 0 | 11,000 | 0 to 11 K | |
May 20 2021 | ATRA | Atara Biotherapeut ... | Murugan Amar | SVP, GC & Secretary | Sell | S | 14.55 | 5,681 | 82,659 | 91,744 | 97.4 K to 91.7 K (-5.83 %) |
May 20 2021 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 14.55 | 3,616 | 52,613 | 168,966 | 172.6 K to 169 K (-2.10 %) |
May 17 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 15.00 | 3,500 | 52,500 | 131,424 | 134.9 K to 131.4 K (-2.59 %) |
Apr 07 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 14.74 | 655 | 9,655 | 134,924 | 135.6 K to 134.9 K (-0.48 %) |